Patent Assignment
Reel/Frame 074220/0249
Assignment of Assignor's Interest
Recorded: 2026-03-30
Pages: 2
Assignor
RAJU, SUNIL
Executed: 2026-01-27
Assignee
UROGEN PHARMA LTD.
9 HA'TA'ASIYA STREET, RA'ANANA, 4365007, ISRAEL
Covered Properties
(3)
Treatment of Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer with a Thermally Gelling Pharmaceutical Composition Containing Mitomycin
Application:
18/784,354 →
Publication:
US 2025/0032409
Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with a Reverse Thermal Gel Containing Mitomycin
Application:
63/515,352 →
Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with a Reverse Thermal Gel Containing Mitomycin
Application:
63/640,252 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement
Mar 18, 2024
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066805/0346 →
Amended and Restated Patent Security Agreement
Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Amended and Restated Patent Security Agreement
Aug 18, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 072472/0233 →
Second Amended and Restated Patent Security Agreement
Mar 2, 2026
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 074994/0338 →